Capital Signal

Amplia Therapeutics Limited (ASX: ATX)

Sector: Health Care

Market cap: A$43M (as of 2 Nov 2026)

Pharmaceutical company advancing a pipeline of Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis.

Data as of 2 Nov 2026.

Recent capital raises

DateTypeAmountPriceDiscountSource
26 Aug 2025SPP$2.65M$0.185% discountFiling ↗
23 July 2025Placement$25M$0.2319.3% discountFiling ↗
27 Nov 2024Rights issue$0.459M$0.12—Filing ↗
1 Nov 2024Rights issue$9.9M$0.12—Filing ↗
14 May 2024Rights issue$4.27M$0.06—Filing ↗

Substantial holders — latest moves

DateHolderMoveHoldingSource
24 June 2026WASHINGTON H. SOUL PATTINSON & COMPANY LIMITEDEntry?% → 5.370%Filing ↗
24 June 2026Pengana Capital Group LimitedEntry?% → 5.370%Filing ↗
22 Jan 2026Platinum Investment Management LimitedDecrease9.31% → 8.12%Filing ↗
30 July 2025Blueflag Holdings Pty Ltd As Trustee For The Blueflag TrustExit—Filing ↗
30 July 2025Acorn Capital LimitedDecrease8.910% → 7.430%Filing ↗

Director trades — on-market

DateDirectorTradeSource
3 Aug 2022Warwick Bonner TongBought 161,107Filing ↗
4 Feb 2022Jane Bell AMBought 222,342Filing ↗
20 Dec 2021Jane Bell AMBought 714,285 Ordinary SharesFiling ↗
1 Sept 2021Jane Bell AMBought 36,268 on 1 September 2021; 557,646 on 2 September 2021Filing ↗

Cash and runway

MetricValueAs ofSource
CashA$21M30 Sept 2026Filing ↗
Runway6.7 quarters30 Sept 2026Filing ↗

Ask about ATX in Claude or ChatGPT

Add the Capital Signal connector at https://capitalsignal.io/api/mcp, then ask:

  • Has ATX raised money in the last year, and at what discount?
  • What was ATX's latest cash position and runway?

Setup guide for Claude, ChatGPT and other MCP clients →

Loading ATX…

Amplia Therapeutics Limited (ASX: ATX): capital raises, holders, director trades | Capital Signal